315 related articles for article (PubMed ID: 25890185)
1. Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets.
Tada N; Kawai K; Tsuno NH; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Oba K; Watanabe T
World J Surg Oncol; 2015 Feb; 13():30. PubMed ID: 25890185
[TBL] [Abstract][Full Text] [Related]
2. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis.
Leibold T; Akhurst TJ; Chessin DB; Yeung HW; Macapinlac H; Shia J; Minsky BD; Saltz LB; Riedel E; Mazumdar M; Paty PB; Weiser MR; Wong WD; Larson SM; Guillem JG
Ann Surg Oncol; 2011 Oct; 18(10):2783-9. PubMed ID: 21476107
[TBL] [Abstract][Full Text] [Related]
4. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
[TBL] [Abstract][Full Text] [Related]
6. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
[TBL] [Abstract][Full Text] [Related]
7. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS
Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408
[TBL] [Abstract][Full Text] [Related]
8. [Effects of neoadjuvant chemoradiotherapy on the rates of sphincter preserving surgery in lower rectal cancer and analysis of their prognostic factors].
Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):419-423. PubMed ID: 27938574
[No Abstract] [Full Text] [Related]
9. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer.
Yoon HJ; Kim SK; Kim TS; Im HJ; Lee ES; Kim HC; Park JW; Chang HJ; Choi HS; Kim DY; Oh JH
Clin Nucl Med; 2013 Jan; 38(1):7-12. PubMed ID: 23242038
[TBL] [Abstract][Full Text] [Related]
10. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864
[TBL] [Abstract][Full Text] [Related]
11. Use of sequential endorectal US to predict the tumor response of preoperative chemoradiotherapy in rectal cancer.
Li N; Dou L; Zhang Y; Jin J; Wang G; Xiao Q; Li Y; Wang X; Ren H; Fang H; Wang W; Wang S; Liu Y; Song Y
Gastrointest Endosc; 2017 Mar; 85(3):669-674. PubMed ID: 27354104
[TBL] [Abstract][Full Text] [Related]
12. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
Kim CW; Yu CS; Yang SS; Kim KH; Yoon YS; Yoon SN; Lim SB; Kim JC
Ann Surg Oncol; 2011 Nov; 18(12):3271-7. PubMed ID: 21537868
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study.
Hongo K; Kazama S; Tsuno NH; Ishihara S; Sunami E; Kitayama J; Watanabe T
World J Surg Oncol; 2015 Jan; 13():7. PubMed ID: 25622595
[TBL] [Abstract][Full Text] [Related]
15. The role of fibrinogen as a predictor in preoperative chemoradiation for rectal cancer.
Lee JH; Hyun JH; Kim DY; Yoo BC; Park JW; Kim SY; Chang HJ; Kim BC; Kim TH; Oh JH; Sohn DK
Ann Surg Oncol; 2015 Jan; 22(1):209-15. PubMed ID: 25384698
[TBL] [Abstract][Full Text] [Related]
16. Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer.
Yeo SG; Kim DY; Park JW; Oh JH; Kim SY; Chang HJ; Kim TH; Kim BC; Sohn DK; Kim MJ
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e193-9. PubMed ID: 21605941
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery.
Kang CM; Lim SB; Hong SM; Yu CS; Hong YS; Kim TW; Park JH; Kim JH; Kim JC
Colorectal Dis; 2016 Jan; 18(1):O10-6. PubMed ID: 26530997
[TBL] [Abstract][Full Text] [Related]
18. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
Cheong C; Shin JS; Suh KW
World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
[TBL] [Abstract][Full Text] [Related]
20. Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.
Clarke TL; White DA; Osborne ME; Shaw AM; Smart NJ; Daniels IR
Ann R Coll Surg Engl; 2017 May; 99(5):373-377. PubMed ID: 28462648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
